Yao Xiaodong, General Manager, attended the pharmaceutical industry research meeting hosted by Qiang Wei, Secretary of the Provincial Party Committee

Focusing on the theme of accelerating the development of the province's bio pharmaceutical industry, Qiang Wei, the secretary of the provincial party committee, conducted a one-day special research in enterprises and universities on April 6, and then hosted the eighth enterprise monthly conference on April 7 to listen to the opinions and suggestions of relevant enterprise leaders. He emphasized that promoting the cluster development of bio pharmaceutical industry is the refocusing of our province's cultivation of strategic emerging industries and an important measure to achieve transformation and upgrading development.   Provincial leaders Zhu Hong, Gong Jianhua, Xie Ru and Li Yihuang accompanied the survey or participated in the symposium.
Qiangwei came to Jiangxi Biological Products Research Institute to enter the workshop, see the products, chat about the market, and learn more about technological innovation, production and operation, market sales, etc. He affirmed that enterprises have been increasing capital investment and actively participating in technology research and development. He said that innovation is the lifeblood of enterprise development. It is necessary to accurately tap the market potential, carry out precise technical research, strengthen links with universities and research institutes, adhere to the combination of production, teaching and research, and continue to promote the innovation driven development strategy. At the symposium, Jiangxi Jiangzhong Pharmaceutical (Group) Co., Ltd., Jiangxi Jiminxin Group Co., Ltd., Renhe (Group) Development Co., Ltd., Jiangxi Fuxiang Pharmaceutical Co., Ltd., Nanchang Lijian Pharmaceutical Co., Ltd., Jiangxi Institute of Biological Products, Jiangxi Hanshi United Stem Cell Technology Co., Ltd., Jiangxi Sanxin Medical Technology Co., Ltd Jiangxi Hongda Medical Device Group Co., Ltd., Jiangxi University of Traditional Chinese Medicine and other enterprises, hospital heads issued insights around the theme of establishing an industry university research association and innovative incentive mechanism, platform construction, sales model, etc. Qiangwei requires relevant departments to carefully study and absorb relevant suggestions.  
On how to make the characteristic industry into a competitive industry and promote the better and faster development of the province's biomedical industry, Qiangwei emphasized that:
——We should upgrade the industrial level. The bio pharmaceutical industry in our province is faced with the dual task of increasing the total volume and improving the quality. All enterprises should deepen the cultivation of traditional Chinese medicine, medical equipment and other advantageous and characteristic industries, give full play to the advantages of factor clustering and supporting perfection, cultivate more leading enterprises, accelerate the construction of a complete industrial chain, strengthen the chain and supplement the chain around the advantageous industries, and effectively improve the overall development level of the industry.
——We should improve our innovation ability. Enterprises should highlight the main role of innovation, vigorously promote innovation in science and technology, industry, products and brands, and focus on technological breakthrough; We should actively focus on the "Internet plus medicine" development model, aim at leading and driving key links in the industrial chain, aim at new diagnosis and treatment technologies, health management, medicine e-commerce and other fields, and strive to expand new growth points. The government should actively build an innovation platform to promote the transformation of innovation achievements; We should innovate financial support methods and support major innovation and industrialization projects.
——The service level should be improved. We should implement the forthcoming Action Plan for the Development of Jiangxi Biomedical Industry and other policy documents, and further improve the promotion mechanism for the development of the biomedical industry. We should do a good job in providing precise assistance to enterprises, implement classified policies, and focus on solving outstanding problems in enterprise financing, talent, marketing, etc. We should strengthen the study and publicity of relevant policies, and guide enterprises to not only strictly accept management, but also make full use of policies.